Journal article
Cellular and structural basis of synthesis of the unique intermediate dehydro-F420-0 in mycobacteria
R Grinter, B Ney, R Brammananth, CK Barlow, PRF Cordero, DL Gillett, T Izoré, MJ Cryle, LK Harold, GM Cook, G Taiaroa, DA Williamson, AC Warden, JG Oakeshott, MC Taylor, PK Crellin, CJ Jackson, RB Schittenhelm, RL Coppel, C Greening
Msystems | AMER SOC MICROBIOLOGY | Published : 2020
Abstract
F420 is a low-potential redox cofactor used by diverse bacteria and archaea. In mycobacteria, this cofactor has multiple roles, including adaptation to redox stress, cell wall biosynthesis, and activation of the clinical antitubercular prodrugs pretomanid and delamanid. A recent biochemical study proposed a revised biosynthesis pathway for F420 in mycobacteria; it was suggested that phosphoenolpyruvate served as a metabolic precursor for this pathway, rather than 2-phospholactate as long proposed, but these findings were subsequently challenged. In this work, we combined metabolomic, genetic, and structural analyses to resolve these discrepancies and determine the basis of F420 biosynthesis ..
View full abstractGrants
Awarded by Monash University
Funding Acknowledgements
This work was supported by an ARC DECRA Fellowship (DE170100310; awarded to C.G.), an NHMRC EL2 Fellowship (APP1178715; awarded to C.G.), an NHMRC New Investigator Grant (APP1142699; awarded to C.G.), an NHMRC grant (APP1139832; awarded to C.J.J., C.G., and G.M.C.), a Monash University Science-Medicine Seed Grant (awarded to C.G. and M.J.C.), Monash University Doctoral Scholarships (awarded to P.R.F.C. and D.L.G.), and an ARC Discovery Grant (DP180102463; awarded to R.L.C.).